PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-11-25

Date Title Company
25-Nov-2024 Justera Health Revises Vesting Schedule of RSU Grant AccessWire
25-Nov-2024 Medicure Reports Financial Results For Quarter Ended September 30, 2024 AccessWire
25-Nov-2024 Empyrean Therapeutics Acquires TLR-2 Antagonist Molecule From Eos Therapies to Advance and Commercialize Breakthrough Cancer Treatment Newswire
25-Nov-2024 Empyrean Therapeutics Acquires TLR-2 Antagonist Molecule From Eos Therapies to Advance and Commercialize Breakthrough Cancer Treatment AccessWire
25-Nov-2024 Juva Life Inc. Updates Shareholders on Court-Appointed Receivership Proceedings AccessWire
25-Nov-2024 Ankle & Foot Centers of America Highlights Vital Role of Podiatric Care for People with Diabetes AccessWire
25-Nov-2024 TraceBot project wins the RAYA Robotics Application of the Year Award 2024 in the “Future Software Trends in Pharma” category TraceBot
25-Nov-2024 Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis Abbott
25-Nov-2024 Concern and anger sees over 4,000 healthcare professionals use social media to wade into physician associate debate, according to new study Creation Healthcare
25-Nov-2024 Innovative Trials celebrates initiative success with industry peers at 2024 PMEA Awards Innovative Trials
25-Nov-2024 iiCON supports new phase II trial of novel pneumococcal vaccine, PnuBioVax iiCON
25-Nov-2024 Wellstack Partners With Hartford HealthCare to Advance Data Integration and Healthcare Analytics AccessWire
25-Nov-2024 Jaguar Health Presenting December 3rd at NobleCon20 and December 5th at the Emerging Growth Conference AccessWire
25-Nov-2024 Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled AccessWire
25-Nov-2024 MRES: Dr. Esmarilda Dankaert Appointed Chief Innovation Officer (CINO) at M2Bio Sciences AccessWire
25-Nov-2024 CNS Pharmaceuticals Presents Update from Ongoing Potentially Pivotal Study of Berubicin Compared with Lomustine in Adult Patients with Recurrent GBM (WHO Grade IV) After Failure of Standard First Line Therapy AccessWire
25-Nov-2024 Neurotech Innovator UNEEG Medical Receives FDA Breakthrough Device Designation Within Monitoring and Diagnostic of Epilepsy AccessWire
25-Nov-2024 TuHURA Biosciences, Inc. (Nasdaq: HURA) Outlines Development Pathway for Single Phase 3 Accelerated Approval Registration Trial in First Line Treatment of Advanced or Metastatic Merkel Cell Carcinoma and Provides Business Update AccessWire
25-Nov-2024 InTheZone Labs Progresses Towards Amazon Listing, Expands Affiliate Program, and Shares Promising Phase One Testing Updates Newswire
25-Nov-2024 Doron Therapeutics Raises $11M Series A to Progress Biologic Regenerative Osteoarthritis Drug into Phase 3 Clinical Studies Newswire